Table 1

Patient characteristics

Total study admissions 4,368 
Unique subjects 2,582 
Mean age (years)* 63.6 ± 15.1 
Female sex 1,325 (51.3) 
Ethnicity  
    White 1,517 (58.8) 
    Black 544 (21.1) 
    Hispanic 273 (10.6) 
    Other/unknown 248 (9.6) 
Insurance  
    Medicare 1,428 (55.3) 
    Medicaid 332 (12.6) 
    Commercial 800 (31.0) 
    Self-pay 22 (0.9) 
Admission service  
    Medical 2,702 (61.9) 
    Surgical 1,660 (38.0) 
    Unknown 6 (0.1) 
Glomerular filtration rate (ml/min) 64.6 ± 38.4 
Mean modified Charlson Comorbidities Index 4.9 ± 3.3 
Received sliding-scale insulin 3,479 (79.6) 
Received scheduled insulin 1,427 (32.7) 
Received oral antihyperglycemic agents 1,530 (35.0) 
Received insulin secretagogues 1,069 (24.5) 
Actual LOS (days) 4.9 ± 5.5 
Deviation from DRG-based LOS (days) −0.8 ± 5.0 
Mean blood glucose (mg/dl) 168.8 ± 48.0 
Mean days with hypoglycemia 0.1 ± 0.41 
Deceased during the admission 43 (1.0) 
Deceased within a year from discharge§ 388 (17.9) 
Total study admissions 4,368 
Unique subjects 2,582 
Mean age (years)* 63.6 ± 15.1 
Female sex 1,325 (51.3) 
Ethnicity  
    White 1,517 (58.8) 
    Black 544 (21.1) 
    Hispanic 273 (10.6) 
    Other/unknown 248 (9.6) 
Insurance  
    Medicare 1,428 (55.3) 
    Medicaid 332 (12.6) 
    Commercial 800 (31.0) 
    Self-pay 22 (0.9) 
Admission service  
    Medical 2,702 (61.9) 
    Surgical 1,660 (38.0) 
    Unknown 6 (0.1) 
Glomerular filtration rate (ml/min) 64.6 ± 38.4 
Mean modified Charlson Comorbidities Index 4.9 ± 3.3 
Received sliding-scale insulin 3,479 (79.6) 
Received scheduled insulin 1,427 (32.7) 
Received oral antihyperglycemic agents 1,530 (35.0) 
Received insulin secretagogues 1,069 (24.5) 
Actual LOS (days) 4.9 ± 5.5 
Deviation from DRG-based LOS (days) −0.8 ± 5.0 
Mean blood glucose (mg/dl) 168.8 ± 48.0 
Mean days with hypoglycemia 0.1 ± 0.41 
Deceased during the admission 43 (1.0) 
Deceased within a year from discharge§ 388 (17.9) 

Data are n, n (%), or means ± SD. Aggregate patient-level characteristics (e.g., demographics) were calculated at the individual patient level, and aggregate admission-level characteristics (e.g., LOS) were calculated at the individual admission level.

*At the time of the first study admission.

†Diabetes was excluded from the computation of the index.

‡Patient-day weighted mean glucose level.

§Calculated for the last study period admission of the 2,582 unique study patients.

Close Modal

or Create an Account

Close Modal
Close Modal